Selected article for: "moderate strong evidence level and strong evidence level"
Author: Lee, Mi Suk; Oh, Jee Youn; Kang, Cheol-In; Kim, Eu Suk; Park, Sunghoon; Rhee, Chin Kook; Jung, Ji Ye; Jo, Kyung-Wook; Heo, Eun Young; Park, Dong-Ah; Suh, Gee Young; Kiem, Sungmin
Title: Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
  • Document date: 2018_6_26
    • ID: sl4u8e6e_186
    Snippet: • For patients requiring ICU admission, the β-lactam + azithromycin/fluoroquinolone combination therapy is recommended over the β-lactam monotherapy. (level of recommendation: strong, level of evidence: moderate)......
    Document: • For patients requiring ICU admission, the β-lactam + azithromycin/fluoroquinolone combination therapy is recommended over the β-lactam monotherapy. (level of recommendation: strong, level of evidence: moderate).

    Search related documents:
    Co phrase search for related documents
    • azithromycin fluoroquinolone and evidence level: 1
    • azithromycin fluoroquinolone and β lactam monotherapy: 1, 2
    • azithromycin fluoroquinolone and ICU admission: 1, 2
    • azithromycin fluoroquinolone and moderate strong evidence level: 1
    • azithromycin fluoroquinolone and moderate strong evidence level recommendation level: 1
    • azithromycin fluoroquinolone and recommendation level: 1
    • azithromycin fluoroquinolone and strong evidence level: 1
    • azithromycin fluoroquinolone β lactam combination therapy and combination therapy: 1, 2
    • azithromycin fluoroquinolone β lactam combination therapy and evidence level: 1
    • azithromycin fluoroquinolone β lactam combination therapy and β lactam monotherapy: 1, 2
    • azithromycin fluoroquinolone β lactam combination therapy and ICU admission: 1, 2
    • azithromycin fluoroquinolone β lactam combination therapy and moderate strong evidence level: 1
    • azithromycin fluoroquinolone β lactam combination therapy and moderate strong evidence level recommendation level: 1
    • azithromycin fluoroquinolone β lactam combination therapy and recommendation level: 1
    • azithromycin fluoroquinolone β lactam combination therapy and strong evidence level: 1
    • combination therapy and evidence level: 1, 2, 3, 4
    • combination therapy and β lactam monotherapy: 1, 2, 3, 4, 5, 6, 7
    • combination therapy and ICU admission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • combination therapy and ICU admission require: 1